Citation: | CHENG Li, MIN Yong-long, WAN Sheng, HE Da, CHEN Fang, ZHANG Yan-min, XIONG Fei. Comparison of calcium-phosphorus metabolism between peritoneal dialysis and hemodialysis patients and analysis of influencing factors[J]. Journal of Clinical Nephrology, 2020, 20(11): 886-890. DOI: 10.3969/j.issn.1671-2390.2020.11.007 |
[1] |
Liyanage T,Ninomiya T,Jha V,et al.Worldwide access to treatment for end-stage kidney disease:a systematic review[J]. Lancet,2015,385(9981):1975-1982.DOI: 10.1016/s0140-6736(14)61601-9.
|
[2] |
Saran R,Li Y,Robinson B,et al.USrenal data system 2014 annual data report:epidemiology of kidney disease in the United States[J]. Am J Kidney Dis,2015,66(1 suppl 1):Svii,S1-Svii,S305.DOI: 10.1053/j.ajkd.2015.05.001.
|
[3] |
Xue J,Li H,Zhou Q,et al.Comparison of peritoneal dialysis with hemodialysis on survival of diabetic patients with end-stage kidney disease:a meta-analysis of cohort studies[J]. Ren Fail,2019,41(1):521-531.DOI: 10.1080/0886022x.2019.1625788.
|
[4] |
Waziri B,Duarte R,Naicker S.Chronic kidney disease-mineral and bone disorder(CKD-MBD):current perspectives[J]. Int J Nephrol Renovasc Dis,2019,12:263-276.DOI: 10.2147/ijnrd.s191156.
|
[5] |
Wang M,Obi Y,Streja E,et al.Association of parameters of mineral bone disorder with mortality in patients on hemodialysis according to level of residual kidney function[J]. Clin J Am Soc Nephrol,2017,12(7):1118-1127.DOI: 10.2215/cjn.11931116.
|
[6] |
中国医师协会肾脏病医师分会血液透析充分性协作组.中国血液透析充分性临床实践指南[J]. 中华医学杂志,2015,95(34):2748-2753.DOI: 10.3760/cma.j.issn.0376-2491.2015.34.004.
|
[7] |
Isakova T,Nickolas TL,Denburg M,et al.KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis,evaluation,prevention,and treatment of chronic kidney disease-mineral and bone disorder(CKD-MBD)[J]. Am J Kidney Dis,2017,70(6):737-751.DOI: 10.1053/j.ajkd.2017.07.019.
|
[8] |
Fang X,Kang M,Chen D,et al.Comparison of mortality between peritoneal dialysis and hemodialysis in polycystic kidney disease[J]. Ren Fail,2019,41(1):14-15.DOI: 10.1080/0886022x.2018.1487867.
|
[9] |
Banshodani M,Kawanishi H,Moriishi M,et al.Association betweendialysis modality and cardiovascular diseases:a comparison between peritoneal dialysis and hemodialysis[J]. Blood Purif,2020,49(3):302-309.DOI: 10.1159/000504040.
|
[10] |
Lamina C,Kronenberg F,Stenvinkel P,et al.Association of changes in bone mineral parameters with mortality in haemodialysis patients:insights from the ARO cohort[J]. Nephrol Dial Transplant,2020,35(3):478-487.DOI: 10.1093/ndt/gfz060.
|
[11] |
由波.腹膜透析和血液透析对尿毒症患者钙磷代谢影响的临床研究[J]. 中国实用医药,2017,12(8):76-78.DOI: 10.14163/j.cnki.11-5547/r.2017.08.033.
|
[12] |
肖艳美,张文贤,董小伟,等.腹膜透析和血液透析对尿毒症患者钙磷代谢影响的临床研究[J]. 中国医药指南,2017,15(32):181.
|
[13] |
Noordzij M,Korevaar JC,Bos WJ,et al.Mineral metabolism and cardiovascular morbidity and mortality risk:peritoneal dialysis patients compared with haemodialysis patients[J]. Nephrol Dial Transplant,2006,21(9):2513-2520.DOI: 10.1093/ndt/gfl257.
|
[14] |
黄力,关洁仪,陈玉平.血液透析与腹膜透析对尿毒症患者在钙、磷代谢中的影响探析[J]. 中国医学创新,2016,13(9):40-42.DOI: 10.3969/j.issn.1674-4985.2016.09.011.
|
[15] |
Palmer SC,Hayen A,Macaskill P,et al.Serum levels of phosphorus,parathyroid hormone,and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease:a systematic review and meta-analysis[J]. JAMA,2011,305(11):1119-1127.DOI: 10.1001/jama.2011.308.
|
[16] |
Kong X,Zhang L,Zhang L,et al.Mineral and bone disorder in Chinese dialysis patients:a multicenter study[J]. BMC Nephrol,2012,13:116.DOI: 10.1186/1471-2369-13-116.
|
[17] |
Dang ZH,Tang C,Li GL,et al.Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau:a multicenter cross-sectional study[J]. Ren Fail,2019,41(1):636-643.DOI: 10.1080/0886022x.2019.1635892.
|
[18] |
Evenepoel P,Meijers BK,Bammens B,et al.Phosphorus metabolism in peritoneal dialysis-and haemodialysis-treated patients[J]. Nephrol Dial Transplant,2016,31(9):1508-1514.DOI: 10.1093/ndt/gfv414.
|
[19] |
林明增,陈霄峰,范佳妮,等.腹膜透析和血液透析对尿毒症患者钙磷代谢影响的临床研究[J]. 中国血液净化,2013,12(9):487-490.DOI: 10.3969/j.issn.1671-4091.2013.09.006.
|
[20] |
Kiss I,Kiss Z,Ambrus C,et al.Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary:results from a nationwide clinical audit[J]. BMC Nephrol,2013,14:155.DOI: 10.1186/1471-2369-14-155.
|
[21] |
Rroji M,Seferi S,Cafka M,et al.Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients?[J]. Int Urol Nephrol,2014,46(1):175-182.DOI: 10.1007/s11255-013-0438-7.
|
[22] |
van der Wijst J,TutakhelOAZ,Bos C,et al.Effects of a high-sodium/low-potassium diet on renal calcium,magnesium,and phosphate handling[J]. Am J Physiol Renal Physiol,2018,315(1):F110-F122.DOI: 10.1152/ajprenal.00379.2017.
|
[23] |
Vallon V,Schroth J,Lang F,et al.Expression and phosphorylation of the Na+-Cl-cotransporter NCC in vivo is regulated by dietary salt,potassium,and SGK1[J]. Am J Physiol Renal Physiol,2009,297(3):F704-F712.DOI: 10.1152/ajprenal.00030.2009.
|